Brief: Theseus Pharmaceuticals Announces Business And Pipeline Highlights And Reports Third Quarter 2022 Financial Results
03/11/2022 11:29
Nov 3 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS ANNOUNCES BUSINESS AND PIPELINE
HIGHLIGHTS AND REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* THESEUS - $221.0 MILLION IN CASH, CASH EQUIVALENTS, AND
INVESTMENTS AS OF SEPT 30, 2022; EXPECTED TO FUND OPERATIONS
INTO THE FOURTH QUARTER OF 2024
* QTRLY LOSS PER SHARE $0.38
* Q3 EARNINGS PER SHARE VIEW $-0.34 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnbd442Fa
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7